Active Pharmaceutical Ingredients Market Research Report 2021-2026: Size, Share, Trends, Growth and Forecast
Active Pharmaceutical Ingredients Market Research Report 2021-2026: Size, Share, Trends, Growth and Forecast
Published by IMARC Services Private Limited
Posted on September 9, 2021
IMARC Group’s latest report, titled “Active Pharmaceutical Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, finds that the global active pharmaceutical ingredients (API) market size reached a value of US$ 200.6 Billion in 2020. Looking forward, IMARC Group expects the global active pharmaceutical ingredients (API) market to exhibit moderate growth during 2021-2026. Active pharmaceutical ingredients (APIs) are the biologically active components of a pharmaceutical drug. They are manufactured through a variety of processes such as chemical synthesis, recombinant DNA, fermentation, isolation, and recovery from natural sources. At present, many governments, especially in developing economies, are promoting the domestic production of APIs to reduce dependence on foreign supply.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Active Pharmaceutical Ingredients Market Trends:
The increasing prevalence of chronic diseases is the primary factor that has led to an increase in the demand for drugs, which in turn has augmented the growth of the global API industry. Moreover, several manufacturers are investing in research and development (R&D) activities to produce better-quality, low-cost APIs that can help in the treatment of diseases beyond the scope of small molecule drugs. Apart from this, pharmaceutical companies are shifting their manufacturing facilities, as well as outsourcing their operations to developing countries for increasing production and reducing input costs. Moreover, the demand for generic APIs is expected to increase significantly as blockbuster drugs worth several billion dollars are projected to lose patent protection in the coming years.
The competitive landscape of the market has also been examined, with some of the key players being Pfizer, Inc., Novartis International AG, Sanofi SA, Boehringer Ingelheim Group, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc. and AbbVie Inc.
Breakup by Drug Type:
Innovative Active Pharmaceutical Ingredients (API)
Generic Active Pharmaceutical Ingredients (API)
Breakup by Manufacturer:
Captive Manufacturers
Merchant API Manufacturers
Innovative Merchant API Manufacturers
Generic Merchant API Manufacturers
Breakup by Synthesis:
Synthetic Active Pharmaceutical Ingredients (API)
Market Breakup by Type
Innovative Synthetic APIs
Generic Synthetic APIs
Biotech Active Pharmaceutical Ingredients (API)
Market Breakup by Type
Innovative Biotech APIs
Biosimilars
Market Breakup By Product
Monoclonal Antibodies
Vaccines
Cytokines
Fusion Proteins
Therapeutic Enzymes
Blood Factors
Market Breakup By Expression System
Mammalian Expression Systems
Microbial Expression Systems
Yeast Expression Systems
Transgenic Animal Systems
Others
Breakup by Therapeutic Application:
Oncology
Cardiovascular and Respiratory
Diabetes
Central Nervous System Disorders
Neurological Disorders
Others
Breakup by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Key highlights of the Report:
Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group 30 N Gould St, Ste R Sheridan, WY 82801, USA Website: https://www.imarcgroup.com/ Email: sales@imarcgroup.com USA: +1-631-791-1145 Follow us on twitter: @imarcglobal Linkedin: https://www.linkedin.com/company/imarc-group
IMARC Group’s latest report, titled “Active Pharmaceutical Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, finds that the global active pharmaceutical ingredients (API) market size reached a value of US$ 200.6 Billion in 2020. Looking forward, IMARC Group expects the global active pharmaceutical ingredients (API) market to exhibit moderate growth during 2021-2026. Active pharmaceutical ingredients (APIs) are the biologically active components of a pharmaceutical drug. They are manufactured through a variety of processes such as chemical synthesis, recombinant DNA, fermentation, isolation, and recovery from natural sources. At present, many governments, especially in developing economies, are promoting the domestic production of APIs to reduce dependence on foreign supply.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Active Pharmaceutical Ingredients Market Trends:
The increasing prevalence of chronic diseases is the primary factor that has led to an increase in the demand for drugs, which in turn has augmented the growth of the global API industry. Moreover, several manufacturers are investing in research and development (R&D) activities to produce better-quality, low-cost APIs that can help in the treatment of diseases beyond the scope of small molecule drugs. Apart from this, pharmaceutical companies are shifting their manufacturing facilities, as well as outsourcing their operations to developing countries for increasing production and reducing input costs. Moreover, the demand for generic APIs is expected to increase significantly as blockbuster drugs worth several billion dollars are projected to lose patent protection in the coming years.
The competitive landscape of the market has also been examined, with some of the key players being Pfizer, Inc., Novartis International AG, Sanofi SA, Boehringer Ingelheim Group, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc. and AbbVie Inc.
Breakup by Drug Type:
Innovative Active Pharmaceutical Ingredients (API)
Generic Active Pharmaceutical Ingredients (API)
Breakup by Manufacturer:
Captive Manufacturers
Merchant API Manufacturers
Innovative Merchant API Manufacturers
Generic Merchant API Manufacturers
Breakup by Synthesis:
Synthetic Active Pharmaceutical Ingredients (API)
Market Breakup by Type
Innovative Synthetic APIs
Generic Synthetic APIs
Biotech Active Pharmaceutical Ingredients (API)
Market Breakup by Type
Innovative Biotech APIs
Biosimilars
Market Breakup By Product
Monoclonal Antibodies
Vaccines
Cytokines
Fusion Proteins
Therapeutic Enzymes
Blood Factors
Market Breakup By Expression System
Mammalian Expression Systems
Microbial Expression Systems
Yeast Expression Systems
Transgenic Animal Systems
Others
Breakup by Therapeutic Application:
Oncology
Cardiovascular and Respiratory
Diabetes
Central Nervous System Disorders
Neurological Disorders
Others
Breakup by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Key highlights of the Report:
Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group 30 N Gould St, Ste R Sheridan, WY 82801, USA Website: https://www.imarcgroup.com/ Email: sales@imarcgroup.com USA: +1-631-791-1145 Follow us on twitter: @imarcglobal Linkedin: https://www.linkedin.com/company/imarc-group